Valdés, María Gabriela
Galván-Femenía, Iván
Ripoll, Vicent Ribas
Duran, Xavier
Yokota, Jun
Gavaldà, Ricard
Rafael-Palou, Xavier
de Cid, Rafael
Article History
First Online: 20 November 2018
Ethics approval and consent to participate
: This study was approved by the institutional review board of the IGTP. The recruitment of NSCLC patients in the pharmacogenomics study was approved by the institutional review board of each participating institution.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.